ASSESSMENT OF THE PHARMACOKINETICS OF CO-ADMINISTERED METFORMIN AND LOBEGLITAZONE, A NOVEL THIAZOLIDINEDIONE ANTIHYPERGLYCEMIC AGENT, IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Shin, D. [1 ]
Kim, T. [1 ]
Jeon, H. [1 ]
Yoon, S. [1 ]
Cho, J. [1 ]
Yu, K. [1 ]
Shin, S. [1 ]
Jang, I. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [41] Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers
    Abel, Samantha
    van der Ryst, Elna
    Rosario, Maria C.
    Ridgway, Caroline E.
    Medhurst, Christine G.
    Taylor-Worth, Richard J.
    Muirhead, Gary J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 : 5 - 18
  • [42] Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers
    Hatorp, V
    Oliver, S
    Su, CAPF
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (12) : 636 - 641
  • [43] Assessment of pharmacokinetic interaction between aliskiren, a novel direct renin inhibitor, and metformin in healthy volunteers.
    Reynolds, C.
    Vaidyanathan, S.
    Dieterich, H. A.
    Yeh, C.
    Howard, D.
    Dole, W. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S110 - S110
  • [44] PHARMACOKINETICS OF CKD-712, A NOVEL ANTI-SEPSIS AGENT, AFTER INTRAVENOUS ADMINISTRATION IN HEALTHY VOLUNTEERS
    Kim, J. W.
    Kim, C. W.
    Yi, S. J.
    Gu, N. Y.
    Kim, D. H.
    Kim, C.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S61 - S61
  • [45] The novel DPP-4 inhibitor BI 1356 (Proposed tradename ONDERO) and metformin can be safely co-administered without dose adjustment
    Graefe-Mody, Ulrike
    Padula, Steven J.
    Dugi, Klaus A.
    Ring, Arne
    DIABETES, 2008, 57 : A164 - A164
  • [46] Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study
    Boinpally, Ramesh
    Borbridge, Lisa
    Wangsadipura, Veronica
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (08): : 930 - 937
  • [47] Pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, and metformin following co-administration in healthy volunteers
    Macha, Sreeraj
    Dieterich, Sabine
    Mattheus, Michaela
    Seman, Leo J.
    Broedl, Uli C.
    Woerle, Hans J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (02) : 132 - 140
  • [48] Comparable Lumefantrine Oral Bioavailability when Co-administered With Oil-Fortified Maize Porridge or Milk in Healthy Volunteers (vol 113, pg 66, 2013)
    Mwebaza, Norah
    Jerling, Markus
    Gustafsson, Lars L.
    Obua, Celestino
    Waako, Paul
    Mahindi, Margarita
    Ntale, Muhammad
    Beck, Olof
    Hellgren, Urban
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (05) : 520 - 520
  • [49] Safety, Pharmacokinetics and Pharmacodynamics of Remogliflozin Etabonate (SGLT2 Inhibitor) and Metformin When Co-Administered in Type 2 Diabetes Mellitus (T2DM) Patients
    Hussey, Elizabeth K.
    Kapur, Anita
    O'Connor-Semmes, Robin L.
    Tao, Wenli
    Poo, Jorge L.
    Dobbins, Robert L.
    DIABETES, 2009, 58 : A157 - A157
  • [50] THE TOLERANCE TO AND PHARMACOKINETICS OF PENCICLOVIR (BRL-39123A), A NOVEL ANTIHERPES AGENT, ADMINISTERED BY INTRAVENOUS-INFUSION TO HEALTHY-SUBJECTS
    FOWLES, SE
    PIERCE, DM
    PRINCE, WT
    STANIFORTH, D
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (05) : 513 - 516
12345